- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Smartcard Helps Communicate Radiation Risks
The radiology department at the University of Colorado in Denver has developed pocket-sized reference card that provides the effective doses and radiation risks of common adult radiologic exams.
The radiology department at the University of Colorado in Denver has developed pocket-sized reference card that provides the effective doses and radiation risks of common adult radiologic exams.
The Adult Dose-Risk Smartcard aims to help referring physicians and patients make more informed decisions about related risks of undergoing or refusing to undergo common radiological examinations. A report of the smartcard was published in the April issue of the Journal of the American College of Radiology.
The smartcard allows the patients to compare doses from various radiologic exams to background radiation, and it provides information on risks of fatal radiation-induced cancer, as last reported by the International Commission on Radiological Protection.
The new tool may be useful in helping patients make decisions, but it does have its drawbacks.
“We recognize that there may be significant age-dependent and gender-dependent variations in both radiation dose and risk estimates,” said R. Edward Hendrick, PhD, lead author of the article. “The Adult Dose-Risk Smartcard does not attempt to incorporate all those variations, but instead to communicate a representative estimate of effective doses and radiations to adults from various radiologic procedures.”
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
